Study | Country Study period |
Population source | Exposure definition | Non-exposure definition | Sample size | Rmk |
---|---|---|---|---|---|---|
Fisher b - Diuretics (Controls unexposed, disease free), 2018 |
USA 1997 - 2011 |
Non-malformed singleton live births randomly selected from birth certificates or hospital discharge records in 10 study sites participating in the National Birth Defects Prevention Study (NBDPS). | Mother with hypertension (chronic or pregnancy-related) that reported use of Diuretics at any time during the month before pregnancy until delivery. |
unexposed, disease free
Normotensive mothers who did not report taking an antihypertensive medication during pregnancy. |
15 / 10050 | Most (83.0%) mothers who began using an antihypertensive medication before or during the first trimester continued use in the second trimester or later (data not shown). |
Fisher b - Diuretics (Controls unexposed, sick), 2018 |
USA 1997 - 2011 |
Non-malformed singleton live births randomly selected from birth certificates or hospital discharge records in 10 study sites participating in the National Birth Defects Prevention Study (NBDPS). | Mother with hypertension (chronic or pregnancy-related) that reported use of Diuretic at any time during the month before pregnancy until delivery. |
unexposed, sick
Mother with untreated hypertension (chronic or pregnancy-related). |
15 / 839 | Most (83.0%) mothers who began using an antihypertensive medication before or during the first trimester continued use in the second trimester or later (data not shown). |
Leather - Bendrofluazide, 1968 |
United Kingdom Not specified. |
Patients that were referred from the antenatal clinics and from obstetric wards, diagnosed with early (before 20 weeks of gestation) or late (normontensive before 20 weeks) hypertension. | Pregnant patients with early hypertension (before 20 gestational weeks) randomly allocated to treatment group, i.e bendrofluazide 5-10 mg daily with potassium supplements and methyldopa 0-5-2g daily in divided doses. |
unexposed, sick
Pregnant patients with early hypertension (before 20 gestational weeks) randomly allocated to control group. |
23 / 24 | Data related to chronic hypertension were reported here. |
Mabie - Hydrochlorothiazide, 1986 |
USA 1980 - 1984 |
Pregnant women with chronic hypertension (>= 140/90 mmHg before pregnancy or at less than 20 week's gestation) who delivered at this hospital during the study period. | Pregnant women with chronic hypertension treated with Hydrochlorothiazide only. |
unexposed, sick
Pregnant women with chronic hypertension without treatment. |
10 / 82 | Data on Hydrochlorothiazide only reported rather than co-administration Methyldopa and hydrochlorothiazide. |
Olesen_Denmark - Diuretics, 2001 |
Denmark 1991 - 1998 |
Women who gave birth (to a singleton) in the county during the study period. | Pregnant women who purchased prescription diuretics (1) any time during their pregnancy and (2) during their third trimester. |
unexposed (general population or NOS)
Pregnant women who did not purchase prescription diuretics during their pregnancy. |
315 / 46998 | |
Olesen_Scotland - Diuretics, 2001 |
Scotland 1993 - 1995 |
Women who gave birth (to a singleton) in the county during the study period. | Pregnant women who purchased prescription diuretics (1) any time during their pregnancy and (2) during their third trimester. |
unexposed (general population or NOS)
Pregnant women who did not purchase prescription diuretics during their pregnancy. |
73 / 35798 | |
Sibai - Diuretics, 1984 |
USA Not specified. |
Pregnant women with a documented history of mild-to-moderate long-term hypertension who were receiving diuretics prior to pregnancy. | Pregnant women receiving diuretics in their first trimester and then randomly assigned to the group allowed to continue their diuretic medication throughout the course of pregnancy. |
unexposed, sick
Pregnant women receiving diuretics in their first trimester and then randomly assigned to the group that discontinued their diuretic medication immediately. |
10 / 10 | All women received diuretics at the entry into the study (1st trimester) and were then randomly to continue or discontinue => outcomes potentially impacted by exposure during first trimester (superimposed pre-eclampsia, SGA, preterm) not reported here. |
Su - Diuretics (Controls unexposed, disease free), 2013 |
Taiwan Jan 2005 - Dec 2005 |
All pregnant women in Taiwan, resulting in singletons. | Pregnant women with chronic hypertension (HTN) that have received a prescription of a diuretic drug for a period of at least 30 days during any time of their pregnancy. |
unexposed, disease free
Pregnant women with no diagnosis of chronic hypertension (HTN), randomly selected from the same cohort. |
371 / 8181 | Women who used more than one type of anti-hypertensive drugs were excluded (n = 722). |
Su - Diuretics (Controls unexposed, sick), 2013 |
Taiwan Jan 2005 - Dec 2005 |
All pregnant women in Taiwan, resulting in singletons. | Pregnant women with chronic hypertension (HTN) that have received a prescription of diuretics for a period of at least 30 days during any time of their pregnancy. |
unexposed, sick
Pregnant women with chronic hypertension (HTN) who had not used any anti-hypertensive drugs. |
371 / 1006 | Women who used more than one type of anti-hypertensive drugs were excluded (n = 722). |
Vaclavik - Diuretics, 2024 |
The Czech Republic 2012 - 2022 |
All births and abortions in the period 2012 - 2022 in the Czech Republic. | Births whose mothers were prescribed Diuretics during pregnancy (for pre-existing hypertension or pregnancy-induced hypertension). |
unexposed, disease free
Births whose mothers had no hypertension. |
-9 / -9 | |
Van der Zande - Diuretics, 2024 |
Worldwide 2007 - 2018 |
Pregnant patients with structural heart disease, included in the Registry from 2007 up to 2018. | Pregnant women who used diuretics at any point during pregnancy, excluding use only during delivery or only prior to pregnancy. |
unexposed, sick
Pregnant women who did not use diuretics during pregnancy. |
382 / 5357 | Structural heart disease: including congenital and valvular heartdisease, prosthetic heart valves, cardiomyopathy, ischaemic heart disease, aortopathy and pulmonary arterial hypertension. Furosemide was by far the most frequently used diuretic (86%). |
Study | Country Study period |
Case | Control | Sample size | Rmk |
---|---|---|---|---|---|
Caton - Diuretics, 2009 |
USA 1997 - 2003 |
Cases of cardiovascular malformations in live births, fetal deaths occurring after 20 weeks, and elective pregnancy terminations. | Live births without birth defects randomly selected from birth certificates or hospital discharge listings in the same geographic areas as the cases. | 5021 / 4796 | Overlapping: Fisher 2017 included data published by Caton 2009 based on a longer period study (1997-2011 versus 1977-2003), more cases and 2 control groups. Fisher 2017 was used rather than Caton 2009 (except for Ebstein anomaly and aorta coarctation). |
Czeizel - Furosemide, 1999 |
Hungary 1980 - 1996 |
Newborn infants (including infant deaths and usual stillborn fetuses) with congenital abnormalities. | Newborn infants (including infant deaths and usual stillborn fetuses) without congenital abnormalities, matched according to gender, birth week and district of parents’ residence. | 22865 / 38151 | This register is used to study several diuretics. To avoid redundancy of case and controls, only 1 of these substances was used in the class meta-analysis: this one with more exposed cases in T1 or higher OR if equal nbs => NTD not reported here. |
Fisher - Diuretics (Controls unexposed, disease free), 2017 |
USA 1997 - 2011 |
Cases of cardiovascular malformations in live births, fetal deaths occurring after 20 weeks, and elective pregnancy terminations. (According to Caton 2009) | Nonmalformed live births randomly selected from birth certificates or hospital discharge records in each study site. | 10625 / 11137 | Overlapping: Fisher 2017 included data published by Caton 2009 based on a longer period study (1997-2011 versus 1977-2003), more cases and 2 control groups. Fisher 2017 was used rather than Caton 2009 (except for Ebstein anomaly and aorta coarctation). |
Fisher - Diuretics (Controls unexposed, sick), 2017 |
USA 1997 - 2011 |
Cases of cardiovascular malformations in live births, fetal deaths occurring after 20 weeks, and elective pregnancy terminations. (According to Caton 2009) | Nonmalformed live births randomly selected from birth certificates or hospital discharge records in each study site. | 10625 / 11137 | Overlapping: Fisher 2017 included data published by Caton 2009 based on a longer period study (1997-2011 versus 1977-2003), more cases and 2 control groups. Fisher 2017 was used rather than Caton 2009 (except for Ebstein anomaly and aorta coarctation). |
Fisher a - Diuretics, 2018 |
USA 1997 - 2011 |
All cases (liveborn, stillborn after 20 weeks gestation, or induced abortions) with an eligible defect within the study time period and geographic areas. | Live births not affected by a birth defect randomly selected from birth certificates or hospital discharge records to represent the base population from which cases were selected in each study site. | 17038 / 11477 | Only OR provided by authors were reported (raw data not reported) because of discrepancies between crude OR provided by authors and raw data. Outcomes without OR provided by authors not reported here. |
Kramer - Diuretics, 1987 |
USA 1970 - 1979 |
Infants diagnosed with neuroblastoma, histologically confirmed. | Randomly selected sibling without neuroblastoma within the cases family. | 86 / -9 | Authors provided 90% confidence intervals and 2 control groups: 1 selected by telephone random digit dialing and 1 among sibling of cases's family => Sibling control preferred because more potential confounders (genetic, environ.) took into consideration. |
McCredie - Diuretics, 1994 |
Australia 1985 - 1989 |
All children aged 0 to 14 years, who were newly diagnosed with a primary malignant tumour of the brain (ICD-9 191) or cranial nerves (ICD-9 192.0) reported to the NSW Central Cancer Registry. | Children matched by age and sex randomly selected in a random sample of children of women aged 20 to 55 years and living in the designated area. | 82 / 164 | |
Medveczky - Hydrochlorothiazide, 2004 |
Hungary 1980 - 1996 |
Newborn infants (including infant deaths and usual stillborn fetuses) with Neural tube defects with non-syndromic (i.e. isolated anencephaly, spina bifida aperta/cystica, encephalocele). | Newborn infants (including infant deaths and usual stillborn fetuses) without congenital abnormalities. | 1202 / 38151 | This register is used to study several diuretics. To avoid redundancy of case and controls, only 1 of these substances was used in the class meta-analysis: this one with more exposed cases in T1 or higher OR if equal nbs (i.e. Hydrochlorothiazide). |
Nakhai-Pour - Diuretics, 2010 |
Canada 1998 - 2003 |
Mothers who gave birth to a baby with a major congenital malformation (1st study). Newborns small for gestational age (a birth weight less than the 10th percentile for that gestational age and gender according to the Canadian gender-specific references) (2nd study). | Mothers who gave birth to babies without any major or minor congenital malformation diagnosed during the same time period (1st study). Newborns not small for gestational age (2nd study). | 4155 / 54878 | Sum of Diuretics thiazide and K sparing diuretics (possible because monotherapy). Major congenital malformations: number of cases: 4,155; number of controls: 54,878.Small-for-gestational-age: number of cases: 7,445; number of controls: 48,889. |
Orimoloye - Diuretics, 2024 |
Taiwan 2004 - 2015 |
Infants with cancer (all types) diagnosed before age 13. | Infants without cancer (all types) at the age 13. | 2780 / 2291512 | |
Schwartzbaum - Diuretics, 1992 |
USA 1979 - 1986 |
Children under age 9 years, newly diagnosed with neuroblastoma. | Children under age 9 years, newly diagnosed with acute lymphocytic leukemia, Wilms' tumor, acute nonlymphocytic leukemia, non-Hodgkin's lymphoma, rhabdomyosarcoma, Hodgkin's disease, Ewing's sarcoma, soft tissue sarcoma, and osteosarcoma. | 101 / 690 | |
Sorensen - Diuretics, 2003 |
Denmark 1959 - 1961 |
Schizophrenia in the offspring. | Cohort comparison subjects (NOS). | 84 / 7782 | 'The definition used here most likely included both cases of chronic hypertension and cases of gestational hypertension.' |
Van Gelder - Diuretics, 2015 |
USA and Canada 1998 - 2010 |
Liveborn or stillborn infants with one of the selected birth defects without chromosomal abnormalities or associated syndromes. | Liveborn infants without birth defects randomly selected from state-wide birth records or from study hospitals covering the geographic catchment areas where the cases were identified. | 5568 / 7253 | Any use of antiadrenergic agents, angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptor blockers, calcium channel blockers, diuretics, or direct vasodilators at any time from the month before pregnancy to the end of pregnancy. |
Van Zutphen - Diuretics, 2014 |
USA 1997 - 2009 |
All cases (liveborn, stillborn after 20 weeks gestation, or induced abortions) with severe hypospadias (ie, subcoronal or penile, scrotal, or perineal meatal opening) diagnosed at the time of physical examination, surgery, or autopsy. | Male live births without birth defects randomly selected from birth certificates or hospital discharge listings in the same population as the case neonates. | 2131 / 5129 | Mothers reporting antihypertensive medications for the treatment of other indications (eg, b-blockers for migraine headaches) were excluded from the analyses. Overlapping: Caton 2008 (1997-2002) totally included in Van Zutphen 2014 (1997-2009). |